ArticleScientific reports2026
CSF1 regulates inflammation and apoptosis in intervertebral disc degeneration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intervertebral disc degeneration (IVDD) is a condition that severely impairs the quality of life for patients and is becoming increasingly prominent in aging societies. There is a pressing need to further investigate the mechanisms underlying the initiation and progression of IVDD. Current therapeutic approaches exhibit inconsistent efficacy, highlighting the urgency for the exploration of novel treatment strategies. In this study, we analyzed microarray datasets GSE147383 and GSE124272, downloaded from the Gene Expression Omnibus (GEO) database, which encompass 12 normal samples and 12 samples from patients with lumbar disc herniation. Utilizing R software, STRING, and various databases, we identified differentially expressed genes (DEGs) and constructed a protein-protein interaction (PPI) network. A total of 52 common DEGs were filtered from the datasets. The aim of this study was to investigate the effects of CSF1 knockdown on the inflammatory response and apoptosis in nucleus pulposus cells and to explore the relationship between peripheral blood CSF1 levels and IVDD. Employing cell culture and plasmid transfection techniques, along with the detection of inflammatory markers and analysis of cellular apoptosis, we found that CSF1 knockdown significantly reduced the expression levels of inflammation-related proteins in disc cells, indicating that CSF1 plays a crucial role in the regulation of inflammation and survival in disc cells. Serum testing from human sources also confirmed the significant role of CSF1 in the progression of IVDD. In summary, this study unravels the key role of CSF1 in intervertebral disc degeneration, providing a theoretical foundation for new treatment strategies and laying a solid foundation for future clinical applications. Future research should focus on the clinical application of CSF1 as a biomarker and its differential roles in various pathological states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.